-
Multimodal immunogenomic biomarker analysis of tumors from pediatric patients enrolled to a phase 1-2 study of single-agent atezolizumab
Study
EGAS00001006004
-
Novel mutations in TOP2A in gliomas
Study
EGAS00001004556
-
Multi-omics integration reveals only minor long-term molecular and functional sequelae in immune cells of individuals recovered from COVID-19
Study
EGAS00001005529
-
The endometrial transcription landscape of MRKH syndrome
Study
EGAS00001004601
-
Understanding_the_multicellular_dynamics_of_clear_cell_renal_cell_carcinoma___visium
Study
EGAS00001006045
-
Patient-tailored design for selective co-inhibition of leukemic cell subpopulations
Study
EGAS00001004614
-
Understanding_hematopoietic_stem_cell_mobilization_and_engraftment_
Study
EGAS00001004620
-
Germline variants in patients with rare cancers and their implications for precision cancer medicine: experiences from the Multicenter MASTER Trial by the German Cancer Consortium (HIPO_021)
Study
EGAS00001005537
-
ATAC-seq/ChIP part
Study
EGAS00001006520
-
Pediatric study using genome sequencing
Study
EGAS00001005553